Bioanalytical Testing Services Market Analysis

The analytical method used for the analysis of biological/biotechnological products is known as bioanalytical testing. Analytical techniques plays a vital role in biotechnology and pharmaceuticals manufacturing. Bioanalytical tests are used in drug discovery, drug development, as well as in the commercialization of drugs.

Market Dynamics:

Increase in burden of chronic diseases, high demand for novel therapeutics, increasing number of clinical trials and drug approvals, increasing preference for outsourcing analytical testing, and the outbreak of COVID-19 are major factors expected to drive growth of the global bioanalytical testing services market over the forecast period.

For instance, in June 2020, BioAgilytix, a global provider of contract bioanalytical testing services, announced that it is now offering customizable COVID-19 testing packages to address a breadth of sponsor and employer needs stemming from the COVID-19 pandemic. Furthermore, Triangle Laboratory, a leading bioanalytical testing laboratory specializing in ligand binding and cell-based assays, announced the bioanalytical service to COVID-19 related studies.

Key features of the study:

• This report provides in-depth analysis of the global bioanalytical testing services market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global bioanalytical testing services market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include PPD Inc., Icon Plc, Syneos Health, Laboratory Corporation of America Holdings, and Charles River Laboratories International Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global bioanalytical testing services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bioanalytical testing services market.

Detailed Segmentation:

• Global Bioanalytical Testing Services Market, By Method Type:
  • Small Molecules
  • Large Molecules
• Global Bioanalytical Testing Services Market, By Test Type:
  • Bioavailability and Bioequivalence Studies
  • Pharmacokinetics
  • Pharmacodynamics
  • Other Test Types
• Global Bioanalytical Testing Services Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • PPD Inc.
  • Icon Plc
  • Syneos Health
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International Inc.